Tracompa Injection (Tramadol Hydrochloride)

Adult administration

Tramadol hydrochloride: Administer 50-100 mg by intravenous or intramuscular injection once, then repeat as needed every 4-5 hours. The maximum daily dosage can be up to 400 mg.

This medication may cause seizures if taken in excess of the recommended dosage, so the prescribed dose must be adhered to. This medication should be administered cautiously in patients at risk of seizures only if absolutely necessary. Prolonged use may lead to psychological and physical dependence, so it should be used under strict management in patients with potential for abuse for a short period. Concomitant use of this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, coma, and in severe cases, death, so it should be avoided or used with extreme caution. In patients with certain genetic types, excessive production of the active metabolite of this medication may increase the risk of respiratory depression, so these patients should consider dosage adjustment or alternative medication. This medication should not be administered to children under 12 years old or to adolescents under 18 years old who have undergone tonsillectomy or adenoidectomy. It should not be used in patients with acute alcohol intoxication, central nervous system drug intoxication, severe respiratory depression, head injury, those taking MAO inhibitors, patients with severe renal or hepatic impairment, pregnant or breastfeeding women. Patients taking morphine, those with impaired liver and kidney function, those who consume alcohol, and those with a history of seizures should use this medication cautiously, and dosage adjustments may be necessary. This medication may cause side effects such as drowsiness, dizziness, nausea, etc., so driving or operating hazardous machinery should be avoided after taking it. Additionally, when used in conjunction with other central nervous system depressants, side effects may be exacerbated, so dosage should be reduced, and the patient's condition should be closely monitored. Pregnant or breastfeeding women should not use this medication, especially during breastfeeding, as it may be transmitted to the baby through breast milk and pose risks. In cases of overdose, severe respiratory depression and seizures may occur, requiring immediate emergency treatment, and naloxone may be used as an antidote. When storing this medication, keep it out of reach of children, and store it in its original container to prevent misuse or degradation of quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, skin peeling, pain in the oral or ocular mucosa, severe skin anomalies, shortness of breath, asthma attacks, respiratory abnormalities accompanied by coughing and fever, respiratory issues, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden

Mild side effects

• Drowsiness
• dizziness
• unsteadiness
• nausea
• vomiting
• abdominal distension
• abdominal discomfort
• abdominal pain
• loss of appetite
• constipation

This medication is sensitive to light, so it should be stored in a container that protects it from light. Furthermore, it is best to store the medication at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness over time.

Appearance

Brown ampule injection containing a colorless and transparent liquid

Package unit

1 milliliter/ampule x 50